Press release
CD Bioparticles Releases New Block Copolymer Micelles for Drug Delivery Research
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of block copolymer micelles for global researchers to help solve the challenges faced in the studies such as limited drug-loading efficiency and yield, unpredictable or uncontrollable degradation rate of the drug-loading cargo, or uncontrollable drug delivery profile. These newly released products are applicable for a variety of potential usages, like biocompatible and biodegradable nanomaterials and bulk material fabrications, drug-delivery cargos with controllable delivery profile, and hydrogels with sol-gel transition useful for reversible encapsulation and delivery.Many new products are released in the block copolymer micelles portfolio, such as Triblock Copolymers, which are vinylically reactive for binding into radical chain synthesized polymers, and AB Diblock Copolymers. For the latter products, the Acrylate-polycaprolactone-b-poly(ethylene glycol)-alkyne, for instance, is a biofunctional amphiphilic block copolymer with alkyne group at the end of PEG and acrylate at the end of polycaprolactone. ACRL-PCL-PEG-Alkyne is used to prepare micelles or nanoparticles with alkyne on the micelle surface for bioconjugation via click chemistry and acrylate in the micelle core for crosslinking. Hydrophobic drugs is encapsulated in the PCL core for targeted drug delivery.
Researchers now are accessible to a series of block copolymer for functional micelles fabrications, and gain lots of benefits such as degradable block copolymer with controllable degradation rate for sustainable release, controllable nanostructure for the assembly, cationic copolymers useful for gene delivery, bock copolymer assembled nanoparticles with controllable size and controllable core-shell ratio, and end-group functionalized block copolymers, useful for crosslinking and conjugation.
"When you're lack of cell-specific or tissue-specific targeting for nanomedicines, or functional groups for further modification/conjugation/crosslinking, or you want to get rid of tedious chemical synthesis and purification, CD Bioparticles will be a good choice for you," said Dr. Robin J. Watts, the product portfolio manager of CD Bioparticles. "CD Bioparticles is committed to developing quality drug delivery products and fulfilling our global clients’ needs, and these block copolymer micelles are added to our product portfolio of biopolymers & synthetic polymers, aiming to provide our customers more selection and value for reliable outcome."
For more detailed information on block copolymer micelles or biopolymers & synthetic polymers, please contact CD Bioparticles directly.
CD Bioparticles
Richard J. Gray
contact@cd-bioparticles.com
About CD Bioparticles
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Releases New Block Copolymer Micelles for Drug Delivery Research here
News-ID: 2223610 • Views: …
More Releases from CD Bioparticles
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents.
CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such…
CD Bioparticles Announces New Protein Magnetic Particles for Bio-application
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a series of protein magnetic particles that can be applied for a variety of research applications such as immunocapture, biopanning and flow cytometry.
These new product are an addition of CD Bioparticles' affinity magnetic particles portfolio. Affinity magnetic particles can be used for affinity purification and separation of antibodies, antigens, proteins and DNA/RNA. These particles have…
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.
With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the…
CD Bioparticles Releases Chitosans for Research Use
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies. These new chitosans and derivatives are with various water solubility, and scientists now are accessible to products like CInd™ analogous hyaluronic acid chitosan, CInd™ carboxymethyl chitosan, CInd™ chitosan azelate and glycol chitin.
One new product in this new release is the CInd™…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
